Corbus Pharmaceuticals Holdings IncNASDAQ:CRBP
- LAST PRICE53.8900
- TODAY'S CHANGE (%)-1.9200 (-3.4402%)
- Bid / Lots50.0000/ 1
- Ask / Lots56.0000/ 2
- Open / Previous Close56.1600 / 55.8100
- Day Range
- 52 Week Range
- Volume183,641
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRBP |
|---|---|---|
| 09:32 ET | 1456 | 55.095 |
| 09:34 ET | 2481 | 56 |
| 09:38 ET | 111 | 56 |
| 09:39 ET | 375 | 55.54 |
| 09:43 ET | 1504 | 54.31 |
| 09:48 ET | 300 | 54.4841 |
| 09:50 ET | 100 | 54.28 |
| 09:52 ET | 100 | 54.39 |
| 09:56 ET | 300 | 54.75 |
| 09:59 ET | 239 | 54.3715 |
| 10:06 ET | 700 | 54.4 |
| 10:10 ET | 2380 | 54.62 |
| 10:14 ET | 100 | 54.859 |
| 10:21 ET | 100 | 54.9319 |
| 10:24 ET | 200 | 54.91 |
| 10:26 ET | 2134 | 54.98 |
| 10:28 ET | 1800 | 55.18 |
| 10:32 ET | 712 | 54.94 |
| 10:35 ET | 695 | 54.975 |
| 10:37 ET | 300 | 55.33 |
| 10:39 ET | 200 | 55.06 |
| 10:42 ET | 171 | 55.175 |
| 10:44 ET | 117 | 55.43 |
| 10:46 ET | 2700 | 55.92 |
| 10:50 ET | 1108 | 56.05 |
| 10:55 ET | 700 | 56.33 |
| 10:57 ET | 300 | 56.04 |
| 11:00 ET | 100 | 56.23 |
| 11:02 ET | 1100 | 56.38 |
| 11:04 ET | 792 | 56.44 |
| 11:06 ET | 1530 | 56.26 |
| 11:08 ET | 600 | 56.305 |
| 11:09 ET | 159 | 56.45 |
| 11:11 ET | 100 | 56.45 |
| 11:15 ET | 368 | 56.43 |
| 11:20 ET | 700 | 56.5 |
| 11:22 ET | 900 | 56.83 |
| 11:24 ET | 200 | 56.675 |
| 11:31 ET | 600 | 56.93 |
| 11:33 ET | 2009 | 56.71 |
| 11:36 ET | 600 | 56.71 |
| 11:38 ET | 300 | 56.745 |
| 11:40 ET | 100 | 56.745 |
| 11:42 ET | 2540 | 56.745 |
| 11:44 ET | 3517 | 56.43 |
| 11:45 ET | 100 | 56.44 |
| 11:51 ET | 230 | 56.44 |
| 11:54 ET | 100 | 56.24 |
| 11:56 ET | 278 | 56.455 |
| 12:05 ET | 420 | 56.4227 |
| 12:07 ET | 100 | 56.59 |
| 12:09 ET | 400 | 56.515 |
| 12:12 ET | 3218 | 56.81 |
| 12:14 ET | 841 | 56.36 |
| 12:16 ET | 352 | 56.31 |
| 12:18 ET | 4440 | 56.29 |
| 12:23 ET | 100 | 55.81 |
| 12:27 ET | 100 | 55.665 |
| 12:32 ET | 400 | 55.8 |
| 12:34 ET | 800 | 55.6 |
| 12:39 ET | 467 | 55.81 |
| 12:41 ET | 200 | 55.9 |
| 12:50 ET | 400 | 56.22 |
| 12:52 ET | 100 | 56.26 |
| 01:08 ET | 1288 | 56 |
| 01:10 ET | 200 | 55.7 |
| 01:15 ET | 500 | 55.64 |
| 01:19 ET | 500 | 55.69 |
| 01:21 ET | 1080 | 55.46 |
| 01:24 ET | 100 | 55.425 |
| 01:26 ET | 100 | 55.69 |
| 01:28 ET | 100 | 55.425 |
| 01:30 ET | 400 | 55.7 |
| 01:32 ET | 1000 | 56.04 |
| 01:35 ET | 567 | 56.11 |
| 01:37 ET | 100 | 56.25 |
| 01:42 ET | 559 | 56.2 |
| 01:46 ET | 1600 | 56.04 |
| 01:48 ET | 1728 | 55.59 |
| 01:50 ET | 2367 | 55.47 |
| 01:51 ET | 100 | 55.5 |
| 01:53 ET | 900 | 55.65 |
| 01:55 ET | 100 | 55.67 |
| 01:57 ET | 100 | 55.81 |
| 02:04 ET | 300 | 55.8 |
| 02:06 ET | 200 | 55.81 |
| 02:08 ET | 200 | 55.76 |
| 02:09 ET | 100 | 55.73 |
| 02:11 ET | 466 | 55.745 |
| 02:13 ET | 300 | 55.94 |
| 02:15 ET | 300 | 55.82 |
| 02:18 ET | 100 | 55.86 |
| 02:20 ET | 100 | 55.645 |
| 02:22 ET | 300 | 55.86 |
| 02:24 ET | 100 | 55.6 |
| 02:26 ET | 300 | 55.74 |
| 02:27 ET | 100 | 55.8699 |
| 02:31 ET | 100 | 55.94 |
| 02:36 ET | 200 | 55.68 |
| 02:40 ET | 200 | 55.565 |
| 02:42 ET | 100 | 55.8 |
| 02:44 ET | 100 | 55.7 |
| 02:47 ET | 102 | 55.68 |
| 02:54 ET | 300 | 55.61 |
| 02:56 ET | 860 | 55.615 |
| 02:58 ET | 100 | 55.6 |
| 03:00 ET | 100 | 55.6 |
| 03:02 ET | 100 | 55.635 |
| 03:03 ET | 100 | 55.485 |
| 03:05 ET | 206 | 55.36 |
| 03:07 ET | 853 | 55.24 |
| 03:12 ET | 300 | 55.44 |
| 03:20 ET | 200 | 55.045 |
| 03:21 ET | 1167 | 54.8 |
| 03:23 ET | 4000 | 54.935 |
| 03:27 ET | 100 | 54.915 |
| 03:30 ET | 200 | 54.925 |
| 03:32 ET | 200 | 54.925 |
| 03:34 ET | 500 | 54.92 |
| 03:36 ET | 270 | 55.01 |
| 03:38 ET | 300 | 54.715 |
| 03:39 ET | 1500 | 54.705 |
| 03:41 ET | 200 | 54.56 |
| 03:43 ET | 200 | 54.565 |
| 03:48 ET | 400 | 54.505 |
| 03:50 ET | 100 | 54.51 |
| 03:52 ET | 1099 | 54.305 |
| 03:54 ET | 400 | 54.3 |
| 03:56 ET | 988 | 54.27 |
| 03:57 ET | 2682 | 54.15 |
| 03:59 ET | 20566 | 53.89 |
Sep 5, 2024
Corbus Pharmaceuticals to Present at the 2024 Cantor Global Health Conference, from 8:00AM ET on Thursday Sep 05, 2024 by Dow Jones
8:00AM ET on Thursday Sep 05, 2024 by Dow Jones
Aug 28, 2024
DJ Corbus Pharmaceuticals Price Target Maintained With a $82.00/Share by RBC Capital, from 8:45AM ET on Wednesday Aug 28, 2024 by Dow Jones
8:45AM ET on Wednesday Aug 28, 2024 by Dow Jones
Aug 20, 2024
Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung, from 8:00AM ET on Tuesday Aug 20, 2024 by Dow Jones
8:00AM ET on Tuesday Aug 20, 2024 by Dow JonesPress Release: Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung, from 8:00AM ET on Tuesday Aug 20, 2024 by Dow Jones
8:00AM ET on Tuesday Aug 20, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Corbus Pharmaceuticals Holdings Inc | 672.2M | -9.3x | --- |
Humacyte Inc | 671.6M | -4.2x | --- |
Scholar Rock Holding Corp | 685.9M | -3.7x | --- |
Savara Inc | 691.3M | -10.0x | --- |
ProKidney Corp | 692.3M | -4.0x | --- |
Rapport Therapeutics Inc | 695.0M | 0.0x | --- |
Company Information
Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company with a diversified portfolio. The Company's pipeline is comprised of two experimental drugs targeting solid tumors: CRB-701, which is an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, which is an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells. Its pipeline also includes CRB-913, which is a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has in-licensed the intellectual property for CRB-601 from Dr. Stephen Nishimura's laboratory at the University of California, San Francisco. The Company does not own or operate manufacturing facilities and relies on third-party contract manufacturing organizations or licensing partners to supply it with drugs for pre-clinical and clinical studies and commercial activities.
Contact Information
- Headquarters
- 500 River Ridge DriveNORWOOD, MA, United States 02062
- Phone
- 617-963-0103
- Fax
- ---
Executives
- Independent Chairman of the Board
- Alan Holmer
- Chief Executive Officer, Director
- Yuval Cohen
- Chief Financial Officer
- Sean Moran
- Chief Medical Officer
- Dominic Smethurst
- Independent Director
- Anne Altmeyer
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $672.2M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 12.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.58 |
EPS | $-5.82 |
Book Value | $-1.56 |
P/E Ratio | -9.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
